Wikipedia:Articles for deletion/CellSqueeze

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was merge to Klavs F. Jensen#Research. ✗plicit 03:14, 5 February 2022 (UTC)[reply]

CellSqueeze[edit]

[Hide this box] New to Articles for deletion (AfD)? Read these primers!

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

It looks like this article was started around the time this technology was described (~2013). In the 8 years since, I'm not sure this has caught the attention to meet WP:GNG. If I search Pubmed I only get 1 result and it's by the same group that described the method. Is it WP:TOOSOON for an article on CellSqueeze? Alternatively, we could consider moving the material to a new page on the company they formed, SQZ Biotech, but I'm having a hard time finding sources that aren't regular biotech PR stuff. I don't typically work on WP:NCORP-related articles, perhaps someone else will have a better time finding something? Ajpolino (talk) 22:13, 21 January 2022 (UTC)[reply]

Note: This discussion has been included in the list of Science-related deletion discussions. Ajpolino (talk) 22:13, 21 January 2022 (UTC)[reply]
Note: This discussion has been included in the list of Biology-related deletion discussions. Ajpolino (talk) 22:21, 21 January 2022 (UTC)[reply]
Merge to Klavs F. Jensen#Research who is the one of the two leaders of the MIT lab where this was developed and the one where this technology is already best documented. I agree that, despite the highly cited PNAS article, this is TOOSOON for a science article since nobody else seems to be using the technique. It's maybe not TOOSOON for the company which was listed last year and had a therapy recently approved by the FDA. We're fairly likely to want to improve coverage of SQZ Biotech so lets go with an ATD that makes reuse of the content easier. — Charles Stewart (talk) 13:49, 24 January 2022 (UTC)[reply]

Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, ✗plicit 00:25, 29 January 2022 (UTC)[reply]

Merge to Klavs F. Jensen#Research per Chalst reasons. The information can be used, and this preserved attribution should an article on the company be workshopped. Star Mississippi 01:22, 29 January 2022 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.